Wilmington Pharmatech Company

PhaseBio Pharmaceuticals, located in Malvern, PA, is dedicated to developing innovative therapies for cardiovascular diseases, which currently affect one in four individuals. The company aims to address the pressing need for new treatment options by leveraging high-quality science and the expertise of its team to create a unique pipeline of medicines. Committed to improving patient outcomes and enhancing the healthcare system, PhaseBio focuses on overcoming the challenges associated with serious cardiovascular conditions. Their mission underscores a determination to deliver specialized therapies that can provide superior results for patients in need. Generated from the website

Incorporated in 1967, The Consortium is a nonprofit mental health center that provides a range of behavioral care services in western and southwestern Philadelphia. It serves children, adults and senior citizens. The center also offers residential mental health and drug and alcohol counseling solutions. The Consortium serves social, recreational and educational needs of citizens above the age of 60. In addition, it operates the Southwest Senior Center and the Sunshine Senior Center. The center offers school-based programs for children. The Consortium also provides the Across Ages program. It offers case management and outpatient solutions. The center serves individuals with emotional difficulties. The Consortium provides care coordination and community outreach services.

Paratek Pharmaceuticals, based in King Of Prussia, PA, is a biopharmaceutical company dedicated to addressing the critical global public health issue of antimicrobial resistance (AMR). Their FDA-approved tetracycline class antibiotic, Nuzyra, is designed to treat adult patients with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria. With a disciplined team of innovative professionals, Paratek is committed to developing and commercializing new treatment options for complex medical issues, including combating the ongoing pandemic of AMR. Led by CEO Evan Loh, M.D., the company strives to provide life-saving solutions to defeat superbugs and improve public health and national security. Generated from the website